Devyser Diagnostics Q4: Better positioned than ever - Redeye

Redeye missed on sales and EBIT but was positively surprised by the strong gross margin. The quarter was affected by one-offs in OPEX, coupled with seasonality effects. However, we are encouraged by the strong and important activities carried out in and after the quarter, opting for Devyser to deliver impressively during 2024.

Länk till analysen i sin helhet: https://www.redeye.se/research/983312/devyser-diagnostics-q4-better-positioned-than-ever?utm_source=finwire&utm_medium=RSS